...
首页> 外文期刊>Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology >The use of the Geenius(TM) HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa
【24h】

The use of the Geenius(TM) HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa

机译:使用Geenius (TM) HIV-1/2迅速确认测试病人的入学率和通用测试和献血者在非洲喀麦隆、治疗策略

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background and objective In the WHO Universal test and treat strategy, false-positive HIV blood donors and patients may be unnecessarily put under antiretroviral treatment and false-negative subjects may be lost to follow-up. This study assessed the false positivity rate of the Cameroonian national HIV screening testing algorithm and the benefit of a confirmation test in the enrolment of patients and donors in the HIV care programme.
机译:背景和目标的通用测试和治疗策略,假阳性艾滋病毒血液捐助者和病人可能是不必要的在抗逆转录病毒治疗和假阴性受试者失访。评估了错误的积极性的喀麦隆国家艾滋病筛查检测算法和确认测试的好处在病人和捐助者的入学率艾滋病毒方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号